Sulfone antibiotic with anti-inflammatory properties

This page covers all Sulfone antibiotic with anti-inflammatory properties drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Dihydropteroate synthase; neutrophil function and inflammatory mediators, Dihydropteroate synthase (bacterial); neutrophil function and ROS production (host), Dihydropteroate synthase; neutrophil function modulation.

Targets

Dihydropteroate synthase; neutrophil function and inflammatory mediators · Dihydropteroate synthase (bacterial); neutrophil function and ROS production (host) · Dihydropteroate synthase; neutrophil function modulation

Marketed (1)

• Dapsone 7.5 % gel · Derm Research, PLLC · Dermatology
  Dapsone is a sulfone antibiotic that inhibits bacterial dihydropteroate synthase and has anti-inflammatory properties, reducing neutrophil migration and suppressing inflammatory mediators.

Phase 3 pipeline (3)

• Dapsone 5.0% Gel (SEEGPharm) · Seegpharm S.A. · Dermatology
  Dapsone is a sulfone antibiotic that inhibits bacterial dihydropteroate synthase and has anti-inflammatory properties through suppression of neutrophil function and reactive oxygen species production.
• Dapsone 5.0% Gel (Allergan) · Seegpharm S.A. · Dermatology
  Dapsone is a sulfone antibiotic that inhibits bacterial dihydropteroate synthase and has anti-inflammatory properties through suppression of neutrophil function and reactive oxygen species production.
• dapsone gel vehicle · Almirall, S.A. · Dermatology
  Dapsone is a sulfone antibiotic that inhibits bacterial dihydropteroate synthase and has anti-inflammatory properties, reducing neutrophil migration and reactive oxygen species production.